Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 19.35 percent. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $1.373 million which beat the analyst consensus estimate of $350.000 thousand by 292.29 percent. This is a 20.33 percent increase over sales of $1.141 million the same period last year.